Skip to Content
  1. All Products
  2. Year
  3. Shandong Qilu King-Phar Pharmaceutical, China, 2024
-
Shandong Qilu King-Phar Pharmaceutical, China, 2024

Shandong Qilu King-Phar Pharmaceutical, China, 2024

https://www.myauditor.nl/web/image/product.template/7425/image_1920?unique=98ea423

GMP Audit Report

Company
Shandong Qilu King-Phar Pharmaceutical

Product(s)
Ivermectin

Country
China

Audit Year
2024

0.00 € 0.0 EUR 0.00 €

0.00 €

This combination does not exist.

Request Quotation
Ivermectin

 

Share